Key Events This Week
Jul 20: Stock opens at Rs.570.25, marginally down -0.11%
Jul 21: Technical momentum shifts to mildly bullish amid mixed signals
Jul 22: Intraday low hit at Rs.516.90 amid heavy price pressure
Jul 23: Q1 FY27 results show sharp profitability rebound
Jul 24: Reports very positive quarterly financial trend despite market weakness
Are Solara Active Pharma Sciences Ltd latest results good or bad?
2026-07-24 19:18:09Solara Active Pharma Sciences Ltd's latest financial results for Q1 FY27 indicate a significant turnaround in profitability compared to previous quarters, where the company had faced losses. The net profit for the quarter stood at ₹16.31 crores, reflecting a substantial quarter-on-quarter growth of 69.90%. This marks a recovery from the previous quarter's profit of ₹9.60 crores. Additionally, the company reported net sales of ₹381.60 crores, which, while showing a slight sequential decline of 1.47% from ₹387.29 crores in Q4 FY26, demonstrates a robust year-on-year growth of 19.57%. The operating margin, excluding other income, improved to 16.24%, up from 14.89% in the prior quarter, indicating better cost management and operational efficiency. The profit after tax (PAT) margin also expanded to 4.27%, up from 2.48% sequentially, although it remains below the levels typically expected in the pharmaceutical s...
Read full news article
Solara Active Pharma Sciences Ltd is Rated Hold
2026-07-24 10:10:04Solara Active Pharma Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 July 2026. While the rating was revised on that date, the analysis and financial metrics presented here reflect the stock's current position as of 24 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Solara Active Pharma Sciences Ltd Reports Very Positive Quarterly Financial Trend Amid Mixed Market Returns
2026-07-24 08:00:14Solara Active Pharma Sciences Ltd has demonstrated a marked improvement in its financial performance for the quarter ended June 2026, shifting from a positive to a very positive trend. The company’s latest results reveal robust revenue growth, margin expansion, and record profitability metrics, signalling a turnaround in operational efficiency despite a challenging market environment and a recent decline in share price.
Read full news article










